Barbara Ryan
Barbara Ryan
Barbara Ryan Colemanis a fictional character from the American CBS soap opera As the World Turns. In the early 1970s, Barbara was played by a succession of actresses, but the actress most associated with the role is Colleen Zenk, who played her since September 1, 1978. Better known as simply Barbara Ryan she is portrayed as a heroine who experienced many tragedies, mostly at the hands of her controlling ex-husband, the villainous James Stenbeck...
avoid condition educate people
You want to educate people on the condition and how to avoid it.
companies strong survive
Strong companies are going to survive in this sector, and they're going to look more like Pfizer than not.
change higher people point
It doesn't change much. But it does point people to the higher end of the range.
agency government hard
It's hard to think of a government agency Schering-Plough wasn't being investigated by.
beyond both gets good patents victory won
This is as good as it gets for Pfizer. They won a victory on both patents -- well beyond our expectations.
benefit lose money
Merck and Pfizer would probably lose money from a moratorium, ... They have portfolios that would benefit from DTC advertising.
companies deliver fairly results slightly
Expectations are fairly low, and these companies will deliver results that are in-line, or slightly better than expectations.
company gone radical
The company has gone through a radical transformation,
altogether cash certainty clearly company disregard generic given greater industry litigation settle translate tremendous unlikely
Pfizer clearly is a company with tremendous disregard for the generic drug industry and is not given to settling. But it is not altogether unlikely that Pfizer could settle its litigation. If Pfizer could translate some of its cash hoards into greater certainty on this litigation ... I think they would do that.
products quite spending terms today visible
There is a 10-year lag in R&D spending, ... The spending that they're doing today isn't going to be visible in terms of products for quite some time.
fold months street telling tent three waiting wall
Three months ago, Wall Street was telling Pfizer to fold up its tent and go home. Now some of the things we've been waiting for are coming.
currently fairly peers portfolio relative standing
Wyeth is really standing out relative to its peers currently because it has a fairly young portfolio of new drugs,
clear company growth vehicle view
The only company which is a clear growth vehicle in our view is Schering-Plough.
company earnings improve merger pursuing
The only way this company can improve their earnings is through pursuing a merger or by being acquired. It's not very innovative, but it's what they're going to have to do.